{"id":"https://openalex.org/W2943740002","doi":null,"title":"Fibroblast growth factor 9 (FGF9) and FGF-receptors (FGFR) 3 and 4 - impact on the pro-metastatic phenotype of hepatocarcinoma cells?","display_name":"Fibroblast growth factor 9 (FGF9) and FGF-receptors (FGFR) 3 and 4 - impact on the pro-metastatic phenotype of hepatocarcinoma cells?","alternate_titles":[],"publication_year":2016,"publication_date":"2016-01-01","ids":{"openalex":"https://openalex.org/W2943740002","mag":"2943740002"},"language":"en","primary_location":{"id":"mag:2943740002","doi":null,"is_oa":false,"landing_page_url":"https://othes.univie.ac.at/42257/","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2943740002"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048130674","display_name":"Karin Taxauer","orcid":"https://orcid.org/0000-0003-0894-3938","observed_orcids":["https://orcid.org/0000-0003-0894-3938"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Karin Taxauer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0894-3938","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5048130674"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fgf9","display_name":"FGF9","score":0.9559999704360962},{"id":"https://openalex.org/keywords/fgfr3","display_name":"FGFR3","score":0.8510000109672546},{"id":"https://openalex.org/keywords/fgfr4","display_name":"FGFR4","score":1.0},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9890000224113464},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.6129999756813049},{"id":"https://openalex.org/keywords/sirna-knockdown","display_name":"siRNA knockdown","score":0.7059999704360962},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8330000042915344},{"id":"https://openalex.org/keywords/collective-invasion","display_name":"collective invasion","score":0.8209999799728394},{"id":"https://openalex.org/keywords/tumor-spheroids","display_name":"tumor spheroids","score":0.6980000138282776},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.3959999978542328},{"id":"https://openalex.org/keywords/endothelial-barrier","display_name":"endothelial barrier","score":0.3959999978542328},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.36500000953674316}],"concepts":[{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.6267001628875732},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5705734491348267},{"id":"https://openalex.org/C74373430","wikidata":"https://www.wikidata.org/wiki/Q24727126","display_name":"Fibroblast growth factor","level":3,"score":0.43481916189193726},{"id":"https://openalex.org/C82867764","wikidata":"https://www.wikidata.org/wiki/Q24780051","display_name":"Fibroblast growth factor receptor","level":4,"score":0.4253259599208832},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.32761871814727783},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2339082956314087},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07768133282661438}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2943740002","doi":null,"is_oa":false,"landing_page_url":"https://othes.univie.ac.at/42257/","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2974578684","https://openalex.org/W2277070361","https://openalex.org/W2974802504","https://openalex.org/W3023658761","https://openalex.org/W2809431677","https://openalex.org/W3115172181","https://openalex.org/W2975329283","https://openalex.org/W2141125422","https://openalex.org/W3010669019","https://openalex.org/W3000564002"],"abstract_inverted_index":{"Das":[0],"hepatozelullare":[1],"Karzinom":[2],"(HCC)":[3],"ist":[4],"die":[5,14,24,44,120,133,138,179,198,204,223,229,243,263,273,279,283,302,312,321,327,335,358,377,385],"haufigste,":[6],"vorkommende":[7],"Form":[8],"des":[9,129,244],"Leberkarzinoms":[10],"und":[11,97,146,156,185,203,249,265,271,281,307,341],"stellt":[12],"weltweit":[13],"zweithaufigste,":[15],"krebsbezogene":[16],"Todesursache":[17],"dar.":[18],"Viele":[19],"verschiedene":[20],"Risikofaktoren":[21],"sind":[22],"bekannt,":[23],"zur":[25,106],"bosartigen":[26],"Krebserkrankung":[27],"beitragen.":[28],"Jedoch":[29],"gibt":[30],"es":[31,250],"keine":[32],"kurative":[33],"Behandlung":[34,332,386],"fur":[35,384],"fortgeschrittene":[36],"HCC":[37,389],"Stadien.\r\nFruhere":[38],"Arbeiten":[39],"unserer":[40],"Gruppe":[41],"zeigten,":[42,212],"dass":[43,213,349,357],"meisten":[45],"der":[46,51,74,77,79,85,92,115,154,206,215,268,285,360,371],"untersuchten":[47,196],"HCCs":[48],"eine":[49,147,290],"Uberexpression":[50,62],"Fibroblastenwachstumsfaktor\u2010Rezeptoren":[52],"(FGFR)":[53],"3,":[54],"FGFR4":[55,66,98,220],"und/oder":[56],"FGF9,":[57],"ein":[58,381],"FGFR3\u2010Ligand,":[59],"aufweisen.":[60],"Die":[61,152,170,236,330],"von":[63,95,217,247,305,387],"FGFR3":[64,96,130,218,352],"oder":[65,219],"in":[67,339],"Hepatom/Hepatokarzinom":[68,116,181,226,286,372],"Zelllinien":[69,117,143,227,373],"erhohte":[70],"den":[71,81,112,368],"aggressiven":[72,113,369],"Phanotyp":[73,114,370],"Zellen,":[75,287],"wahrend":[76],"Knock\u2010down":[78,94,128,216],"Rezeptoren":[80],"gegenteiligen":[82],"Effekt":[83,103,254],"zeigte.\r\nIn":[84],"vorliegenden":[86],"Arbeit":[87],"untersuchen":[88],"wir,":[89],"ob":[90],"i)":[91,214],"gleichzeitige":[93],"mittels":[99,131,164,176,200,208],"siRNA":[100,132],"einen":[101,259,364],"additiven":[102],"im":[104,186,232,293],"Vergleich":[105],"Einzelrezeptor":[107],"Runterregulierung":[108],"aufweist;":[109],"ii)":[110,256],"FGF9":[111,257,278,350],"unterstutzt;":[118],"iii)":[119,297],"Applikation":[121],"eines":[122],"FGFR1\u20103":[123],"spezifischen":[124],"Tyrosinkinase\u2010Hemmers":[125],"bzw.":[126],"durch":[127,159,173,221,289,311,326,336],"FGF9\u2010induzierten":[134,303],"Effekte":[135,237,304,322],"blockiert":[136],"werden.\r\nFur":[137],"Untersuchungen":[139],"wurden":[140,184,301],"zwei":[141],"Hepatom":[142],"(HepG2,":[144],"Hep3B)":[145],"Hepatokarzinom":[148],"Zelllinie":[149],"(HCC\u20101.2)":[150],"eingesetzt.":[151],"Auflosung":[153],"BEC":[155],"LEC":[157],"Endothelzellbarriere":[158,231],"einzelne,":[160],"maligne":[161],"Zellen":[162],"wurde":[163,175],"Einzelzellen":[165],"Invasion":[166,172],"Assay":[167,192,202,234],"(SCIA)":[168],"ermittelt.":[169],"kollektive":[171],"Tumoremboli":[174],"Spharoiden":[177,309,319],"simuliert,":[178],"aus":[180],"Zelllinen":[182],"geformt":[183],"zirkular":[187],"Chemo\u2010repellent":[188],"induzierenden":[189],"Defekt":[190],"(CCID)":[191],"angewendet":[193],"wurden.":[194],"Zusatzlich":[195],"wir":[197],"Zellvitalitat":[199],"MTT":[201],"Klonbildungsfahigkeit":[205],"Leberkrebszellen":[207,269],"Clonogenicity":[209],"Assay.\r\nUnsere":[210],"Ergebnisse":[211],"siRNA,":[222],"Fahigkeit":[224],"aller":[225],"reduzierte,":[228],"BEC/LEC":[230],"CCID":[233,276,299],"aufzulosen.":[235],"waren":[238,320],"ahnlich":[239],"stark":[240,324],"ausgepragt":[241],"wie":[242],"kombinierten":[245],"Knock\u2010downs":[246],"FGFR3+4":[248],"war":[251],"kein":[252],"additiver":[253],"ersichtlich.":[255],"wies":[258],"starken":[260,365],"Einfluss":[261,366],"auf":[262,270,367],"Vitalitat":[264],"das":[266],"Wachstum":[267],"steigerte":[272],"Klongrose.":[274],"Im":[275,298],"Assay,vergroserte":[277],"Spharoidflache":[280],"verschlimmerte":[282],"Aggressivitat":[284],"was":[288],"vergroserte":[291],"Lochbildung":[292,338],"Endothel":[294],"ersichtlich":[295],"wurde.":[296],"Assay,":[300],"HCC\u20101.2":[306,342],"Hep3B":[308],"allerdings,":[310],"BGJ398":[313,328],"Behandlung,":[314],"komplett":[315],"blockiert.":[316],"In":[317],"HepG2":[318,340],"weniger":[323],"reduzierend":[325],"Applikation.":[329],"siFGFR3":[331],"verringerte":[333],"ebenfalls":[334],"FGF9\u2010induzierte":[337],"Spharoiden.":[343],"Dies":[344],"konnte":[345,376],"darauf":[346],"schliesen":[347],"lassen,":[348],"uber":[351],"agiert.\r\nAbschliesend":[353],"lasst":[354],"sich":[355],"sagen,":[356],"Deregulierung":[359],"FGF9\u2010FGFR3/FGFR4":[361],"Achse":[362,380],"moglicherweise":[363],"hat.":[374],"Somit":[375],"Inhibierung":[378],"dieser":[379],"vielversprechender":[382],"Ansatz":[383],"fortgestrittenem/invasivem":[388],"darstellen.":[390]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2943740002","counts_by_year":[],"updated_date":"2025-11-06T04:12:42.849631","created_date":"2019-05-09T00:00:00"}
